The effects of propranolol on cardiac conduction.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D006328:Cardiac Catheterization; D004071:Digitalis Glycosides / Q000494:pharmacology; D004285:Dogs; D004562:Electrocardiography; D006325:Heart Atria; D006329:Heart Conduction System / Q000187:drug effects*; D006339:Heart Rate; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D010042:Ouabain; D010138:Pacemaker, Artificial; D011342:Procainamide / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology* / Q000627:therapeutic use; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D010042:Ouabain; D011433:Propranolol; D011342:Procainamide